2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Working with MBC

HER2-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum SeriesПодробнее

ER-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum SeriesПодробнее

Research Update for ER-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

Research Update for Triple Negative MBC | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Research Update for HER2-Positive MBC | 2023-2024 EMBRACE MBC Virtual Forum SeriesПодробнее

2022 San Antonio Breast Cancer Symposium Update on MBC | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

Clinical Trials 101 | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

Welcome Session | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

Biomarkers for Treatment and Progression | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Research Update for Triple-Negative MBCПодробнее

Welcome Session | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Research Update for ER-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Research Update for HER2-Positive MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Clinical Trials: What You Need to Know | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Breast Cancer with Brain Metastasis Panel | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Studying Treatment ResistanceПодробнее

2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Expert Panel: Managing Side EffectsПодробнее

Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Living and Aging with MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее